Advertisement

Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part II

      Highlights

      • Patient reported outcomes measurements (PROMs) are an essential component of comprehensive, patient centered care.
      • Practical considerations and challenges to collecting PROMs in routine gynecologic oncology practice are discussed.
      • Pragmatic, disease-specific recommendations for the use of PROMs are provided for women with gynecologic malignancies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Donovan K.A.
        • Donovan H.S.
        • Cella D.
        • Gaines M.E.
        • Penson R.T.
        • Plaxe S.C.
        • et al.
        Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.
        J. Natl. Cancer Inst. Jul 2014; 106
        • Greimel E.R.
        • Bjelic-Radisic V.
        • Pfisterer J.
        • Hilpert F.
        • Daghofer F.
        • du Bois A.
        Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
        Journal of clinical oncology. Feb 1 2006; 24: 579-586
        • von Gruenigen V.E.
        • Huang H.Q.
        • Gil K.M.
        • Gibbons H.E.
        • Monk B.J.
        • Rose P.G.
        • et al.
        Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.
        Cancer. Oct 15 2009; 115: 4857-4864
        • von Gruenigen V.E.
        • Huang H.Q.
        • Gil K.M.
        • Gibbons H.E.
        • Monk B.J.
        • Rose P.G.
        • et al.
        A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study.
        J. Pain Symptom Manag. 2010 May; 39: 839-846
        • Wenzel L.
        • Huang H.Q.
        • Monk B.J.
        • Rose P.G.
        • Cella D.
        Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study.
        Journal of clinical oncology. Aug 20 2005; 23: 5605-5612
        • Wenzel L.B.
        • Huang H.Q.
        • Armstrong D.K.
        • Walker J.L.
        • Cella D.
        Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.
        Journal of clinical oncology. Feb 1 2007; 25: 437-443
        • Jensen S.E.
        • Kaiser K.
        • Lacson L.
        • Schink J.
        • Cella D.
        Content validity of the NCCN-FACT ovarian symptom index-18 (NFOSI-18).
        Gynecol. Oncol. Feb 2015; 136: 317-322
        • Miller K.D.
        • Siegel R.L.
        • Lin C.C.
        • Mariotto A.B.
        • Kramer J.L.
        • Rowland J.H.
        • et al.
        Cancer treatment and survivorship statistics, 2016.
        CA Cancer J. Clin. Jul 2016; 66: 271-289
        • von Gruenigen V.E.
        • Gil K.M.
        • Frasure H.E.
        • Jenison E.L.
        • Hopkins M.P.
        The impact of obesity and age on quality of life in gynecologic surgery.
        Am. J. Obstet. Gynecol. Oct 2005; 193: 1369-1375
        • Arms 3rd, R.G.
        • Sun C.C.
        • Burzawa J.K.
        • Fleming N.D.
        • Nick A.M.
        • Rallapalli V.
        • et al.
        Improvement in quality of life after robotic surgery results in patient satisfaction.
        Gynecol. Oncol. Sep 2015; 138: 727-730
        • Berretta R.
        • Gizzo S.
        • Noventa M.
        • Marrazzo V.
        • Franchi L.
        • Migliavacca C.
        • et al.
        Quality of life in patients affected by endometrial cancer: comparison among laparotomy, laparoscopy and vaginal approach.
        Pathology oncology research. Jul 2015; 21: 811-816
        • Herling S.F.
        • Moller A.M.
        • Palle C.
        • Thomsen T.
        Health-related quality of life after robotic-assisted laparoscopic hysterectomy for women with endometrial cancer—a prospective cohort study.
        Gynecol. Oncol. Jan 2016; 140: 107-113
        • Damast S.
        • Alektiar K.M.
        • Goldfarb S.
        • Eaton A.
        • Patil S.
        • Mosenkis J.
        • et al.
        Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy.
        Int. J. Radiat. Oncol. Biol. Phys. Oct 1 2012; 84: e187-e193
        • Quick A.M.
        • Seamon L.G.
        • Abdel-Rasoul M.
        • Salani R.
        • Martin D.
        Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.
        International journal of gynecological cancer. May 2012; 22: 703-708
        • Karabuga H.
        • Gultekin M.
        • Tulunay G.
        • Yuce K.
        • Ayhan A.
        • Yuce D.
        • et al.
        Assessing the quality of life in patients with endometrial cancer treated with adjuvant radiotherapy.
        International journal of gynecological cancer. Oct 2015; 25: 1526-1533
        • Gao H.
        • Xiao M.
        • Bai H.
        • Zhang Z.
        Sexual function and quality of life among patients with endometrial cancer after surgery.
        International journal of gynecological cancer. Mar 2017; 27: 608-612
        • Rowlands I.J.
        • Lee C.
        • Beesley V.L.
        • Webb P.M.
        Predictors of sexual well-being after endometrial cancer: results of a national self-report survey.
        Supportive care in cancer. Oct 2014; 22: 2715-2723
        • Lin L.L.
        • Brown J.C.
        • Segal S.
        • Schmitz K.H.
        Quality of life, body mass index, and physical activity among uterine cancer patients.
        International journal of gynecological cancer. Jul 2014; 24: 1027-1032
        • Zhang X.
        • Brown J.C.
        • Schmitz K.H.
        Association between body mass index and physical function among endometrial cancer survivors.
        PLoS One. 2016; 11e0160954
        • Fleming N.D.
        • Ramirez P.T.
        • Soliman P.T.
        • Schmeler K.M.
        • Chisholm G.B.
        • Nick A.M.
        • et al.
        Quality of life after radical trachelectomy for early-stage cervical cancer: a 5-year prospective evaluation.
        Gynecol. Oncol. Dec 2016; 143: 596-603
        • Froeding L.P.
        • Ottosen C.
        • Rung-Hansen H.
        • Svane D.
        • Mosgaard B.J.
        • Jensen P.T.
        Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study.
        J. Sex. Med. Feb 2014; 11: 595-604
        • Malmsten C.
        • Hellberg P.
        • Bergmark K.
        • Dahm-Kahler P.
        Long-term fertility, oncological, and quality-of-life outcomes after trachelectomy in early stage cervical cancer.
        Arch. Gynecol. Obstet. Apr 2019; 299: 1033-1041
        • Mantegna G.
        • Petrillo M.
        • Fuoco G.
        • Venditti L.
        • Terzano S.
        • Anchora L.P.
        • et al.
        Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.
        BMC Cancer. Mar 18 2013; 13: 127
        • Long 3rd, H.J.
        • Bundy B.N.
        • Grendys Jr., E.C.
        • Benda J.A.
        • McMeekin D.S.
        • Sorosky J.
        • et al.
        Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
        Journal of clinical oncology. Jul 20 2005; 23: 4626-4633
        • McQuellon R.P.
        • Thaler H.T.
        • Cella D.
        • Moore D.H.
        Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
        Gynecol. Oncol. May 2006; 101: 296-304
        • Moore D.H.
        • Blessing J.A.
        • McQuellon R.P.
        • Thaler H.T.
        • Cella D.
        • Benda J.
        • et al.
        Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
        Journal of clinical oncology. Aug 1 2004; 22: 3113-3119
        • Tewari K.S.
        • Monk B.J.
        Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.
        Curr. Oncol. Rep. Nov 2005; 7: 419-434
        • Janda M.
        • Obermair A.
        • Cella D.
        • Crandon A.J.
        • Trimmel M.
        Vulvar cancer patients' quality of life: a qualitative assessment.
        International journal of gynecological cancer. Sep–Oct 2004; 14: 875-881
        • Novackova M.
        • Halaska M.J.
        • Robova H.
        • Mala I.
        • Pluta M.
        • Chmel R.
        • et al.
        A prospective study in the evaluation of quality of life after vulvar cancer surgery.
        International journal of gynecological cancer. Jan 2015; 25: 166-173
        • Senn B.
        • Gafner D.
        • Happ M.B.
        • Eicher M.
        • Mueller M.D.
        • Engberg S.
        • et al.
        The unspoken disease: symptom experience in women with vulval neoplasia and surgical treatment: a qualitative study.
        European journal of cancer care. Nov 2011; 20: 747-758
        • Basch E.
        The missing voice of patients in drug-safety reporting.
        N. Engl. J. Med. Mar 11 2010; 362: 865-869
        • Carlson J.W.
        • Kauderer J.
        • Walker J.L.
        • Gold M.A.
        • O'Malley D.
        • Tuller E.
        • et al.
        A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.
        Gynecol. Oncol. Jul 2008; 110: 76-82
        • Green M.S.
        • Naumann R.W.
        • Elliot M.
        • Hall J.B.
        • Higgins R.V.
        • Grigsby J.H.
        Sexual dysfunction following vulvectomy.
        Gynecol. Oncol. Apr 2000; 77: 73-77
        • Raphaelis S.
        • Mayer H.
        • Ott S.
        • Mueller M.D.
        • Steiner E.
        • Joura E.
        • et al.
        The impact of written information and counseling (WOMAN-PRO II Program) on symptom outcomes in women with vulvar neoplasia: a multicenter randomized controlled phase II study.
        Gynecol. Oncol. Jul 2017; 146: 114-122
        • Janda M.
        • Obermair A.
        • Cella D.
        • Perrin L.C.
        • Nicklin J.L.
        • Ward B.G.
        • et al.
        The functional assessment of cancer-vulvar: reliability and validity.
        Gynecol. Oncol. May 2005; 97: 568-575
        • Froeding L.P.
        • Greimel E.
        • Lanceley A.
        • Oberguggenberger A.
        • Schmalz C.
        • Radisic V.B.
        • et al.
        Assessing patient-reported quality of life outcomes in vulva cancer patients: a systematic literature review.
        International journal of gynecological cancer. May 2018; 28: 808-817
        • Armbruster S.D.
        • Song J.
        • Bradford A.
        • Carmack C.L.
        • Lu K.H.
        • Basen-Engquist K.M.
        Sexual health of endometrial cancer survivors before and after a physical activity intervention: a retrospective cohort analysis.
        Gynecol. Oncol. Dec 2016; 143: 589-595
        • Bergmark K.
        • Avall-Lundqvist E.
        • Dickman P.W.
        • Henningsohn L.
        • Steineck G.
        Vaginal changes and sexuality in women with a history of cervical cancer.
        N. Engl. J. Med. May 6 1999; 340: 1383-1389
        • DeSimone M.
        • Spriggs E.
        • Gass J.S.
        • Carson S.A.
        • Krychman M.L.
        • Dizon D.S.
        Sexual dysfunction in female cancer survivors.
        Am. J. Clin. Oncol. Feb 2014; 37: 101-106
        • Jewell E.L.
        • Aghajanian C.
        • Montovano M.
        • Lewin S.N.
        • Baser R.E.
        • Carter J.
        Association of ss-hCG surveillance with emotional, reproductive, and sexual health in women treated for gestational trophoblastic neoplasia.
        Journal of women's health (2002). Mar 2018; 27: 387-393
        • Doll K.M.
        • Barber E.L.
        • Bensen J.T.
        • Snavely A.C.
        • Gehrig P.A.
        The health-related quality of life journey of gynecologic oncology surgical patients: implications for the incorporation of patient-reported outcomes into surgical quality metrics.
        Gynecol. Oncol. May 2016; 141: 329-335
        • Donovan K.A.
        • Taliaferro L.A.
        • Alvarez E.M.
        • Jacobsen P.B.
        • Roetzheim R.G.
        • Wenham R.M.
        Sexual health in women treated for cervical cancer: characteristics and correlates.
        Gynecol. Oncol. Feb 2007; 104: 428-434
        • Huffman L.B.
        • Hartenbach E.M.
        • Carter J.
        • Rash J.K.
        • Kushner D.M.
        Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide.
        Gynecol. Oncol. Feb 2016; 140: 359-368
        • Sporn N.J.
        • Smith K.B.
        • Pirl W.F.
        • Lennes I.T.
        • Hyland K.A.
        • Park E.R.
        Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred?.
        Psycho-oncology. Sep 2015; 24: 1167-1173
        • Stead M.L.
        • Fallowfield L.
        • Brown J.M.
        • Selby P.
        Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study.
        BMJ (Clinical research ed). Oct 13 2001; 323: 836-837
        • Wiggins D.L.
        • Wood R.
        • Granai C.O.
        • Dizon D.S.
        Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO).
        J. Psychosoc. Oncol. 2007; 25: 61-70
        • Baser R.E.
        • Li Y.
        • Carter J.
        Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
        Cancer. Sep 15 2012; 118: 4606-4618
        • Rosen R.
        • Brown C.
        • Heiman J.
        • Leiblum S.
        • Meston C.
        • Shabsigh R.
        • et al.
        The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
        Journal of sex & marital therapy. Apr–Jun 2000; 26: 191-208
        • Boehmer U.
        • Timm A.
        • Ozonoff A.
        • Potter J.
        Applying the Female Sexual Functioning Index to sexual minority women.
        Journal of women's health (2002). Apr 2012; 21: 401-409
        • Oberguggenberger A.S.
        • Nagele E.
        • Inwald E.C.
        • Tomaszewski K.
        • Lanceley A.
        • Nordin A.
        • et al.
        Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.
        Cancer medicine. Mar 2018; 7: 635-645
        • Velikova G.
        • Awad N.
        • Coles-Gale R.
        • Wright E.P.
        • Brown J.M.
        • Selby P.J.
        The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views.
        Psycho-oncology. Jul 2008; 17: 690-698
        • Munoz A.R.
        • Kaiser K.
        • Yanez B.
        • Victorson D.
        • Garcia S.F.
        • Snyder M.A.
        • et al.
        Cancer experiences and health-related quality of life among racial and ethnic minority survivors of young adult cancer: a mixed methods study.
        Supportive care in cancer. 2016 Dec; 24: 4861-4870